Rhön-Klinikum Aktiengesellschaft (RHK) Given a €22.00 Price Target at Deutsche Bank

Rhön-Klinikum Aktiengesellschaft (ETR:RHK) received a €22.00 ($26.19) price target from equities research analysts at Deutsche Bank in a note issued to investors on Friday. The brokerage currently has a “neutral” rating on the stock. Deutsche Bank’s price target would suggest a potential downside of 24.42% from the stock’s current price.

Other analysts also recently issued research reports about the company. Independent Research set a €28.00 ($33.33) price objective on Rhön-Klinikum Aktiengesellschaft and gave the stock a “neutral” rating in a report on Monday, August 14th. Berenberg Bank set a €26.50 ($31.55) price objective on Rhön-Klinikum Aktiengesellschaft and gave the stock a “neutral” rating in a research note on Monday, August 7th. Commerzbank set a €25.00 ($29.76) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a “neutral” rating in a report on Monday, September 18th. Warburg Research set a €26.30 ($31.31) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a “neutral” rating in a report on Tuesday, November 7th. Finally, Jefferies Group set a €17.60 ($20.95) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a “sell” rating in a report on Thursday, August 3rd. Four equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The company has an average rating of “Hold” and an average price target of €25.05 ($29.82).

Rhön-Klinikum Aktiengesellschaft (ETR:RHK) opened at €29.11 ($34.65) on Friday. Rhön-Klinikum Aktiengesellschaft has a 12 month low of €22.66 ($26.98) and a 12 month high of €30.65 ($36.49).

TRADEMARK VIOLATION NOTICE: This piece of content was posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/01/rhon-klinikum-aktiengesellschaft-rhk-given-a-22-00-price-target-at-deutsche-bank.html.

Rhön-Klinikum Aktiengesellschaft Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhön-Klinikum Aktiengesellschaft (ETR:RHK)

Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply